Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2589810

CNCC(=O)NC(Cc1ccc(O)cc1)C(N)=O.O=C(O)C(F)(F)F

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 4/20 0.52
PTPN2 P17706 2/20 0.52
ACE P12821 3/20 0.50
NPY4R P50391 1/20 0.50
OPRD1 P41143 5/20 0.45
OPRM1 P35372 4/20 0.45
OPRK1 P41145 1/20 0.45
MDM4 O15151 1/20 0.45
MDM2 Q00987 1/20 0.45
HPGDS O60760 2/20 0.43
PTPRA P18433 1/20 0.43
PTPN6 P29350 1/20 0.43
PTPN11 Q06124 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL2587894 0.90 PTPN1 (0.52) PTPN1PTPN2ACEHPGDSPTPRA
SCHEMBL2589812 0.84 PTPN1 (0.44) PTPN1PTPN2ACENPY4RPTPRA
SCHEMBL16602248 0.83 HDAC3 (0.55) PTPN1HPGDS
SCHEMBL16656665 0.83 OPRD1 (0.48) ACEOPRD1OPRM1OPRK1MDM4
SCHEMBL25627130 0.81 PTPN1 (0.52) PTPN1PTPN2ACEOPRD1OPRM1
SCHEMBL6757142 0.80 PTPN2 (0.52) PTPN1PTPN2ACENPY4ROPRD1
SCHEMBL15839930 0.79 OPRD1 (0.54) OPRD1OPRM1OPRK1
SCHEMBL4386989 0.77 PTPN2 (0.52) PTPN1PTPN2ACEHPGDS
SCHEMBL5594950 0.77 PTPN2 (0.52) PTPN1PTPN2ACEHPGDS
Trifluoroacetic Acid SCHEMBL2588851 0.77 TACR1 (0.55) ACEMDM4MDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8350077-B2 Amides of creatine, method of their preparation, and remedy possessing a neuroprotective activity VERTEX CLOSED JOINT STOCK COMPANY (RU) 2013-01-08 US disclosed
US-20110269986-A1 AMIDES OF CREATNE, METHOD OF THEIR PREPARATION, AND REMEDY POSSESSING A NEUROPROTECTIVE ACTIVITY AMIDE BEVERAGE COMPANY, LLC 2011-11-03 US disclosed